Coya Therapeutics Inc. (NASDAQ: COYA)
$7.65
-0.0500 ( -0.65% ) 65.5K
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Market Data
Open
$7.65
Previous close
$7.70
Volume
65.5K
Market cap
$116.75M
Day range
$7.51 - $7.78
52 week range
$3.21 - $10.69
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 19, 2024 |
| 4 | Insider transactions | 1 | Jan 04, 2024 |
| 3 | Insider transactions | 2 | Dec 29, 2023 |
| 8-k | 8K-related | 13 | Dec 20, 2023 |
| 8-k | 8K-related | 19 | Dec 06, 2023 |
| 8-k | 8K-related | 13 | Nov 08, 2023 |
| 10-q | Quarterly Reports | 52 | Nov 08, 2023 |
| 8-k | 8K-related | 13 | Aug 21, 2023 |